Skip to content

The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease

The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease - The beneficial effect of branched-chain amino acids for patients with HCV related chronic liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016750
Enrollment
100
Registered
2015-03-09
Start date
2014-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCV related chronic liver disease

Interventions

Patients who obtained the consent, administer the BCAA enriched supplement for 12 weeks in addition to the original treatment. containing

Sponsors

Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age, over 20 years old 2) Male and female 3) Patients who has inslin resistance 4) Patients who has no HCC 5) Patients who obtained the consent

Exclusion criteria

Exclusion criteria: 1) Cirrotic patients with BCAA formulation while taking 2) Patients during interferon therapy in chronic hepatitis C, cirrhosis 3) Patients receiving medication for diabetes 4) Patients in the intake of dietary supplements containing the BCAA and zinc 5) Patients for branched-chain amino acids and zinc formulation, with a history of hypersensitivity 6) Pregnant woman and women who may possibly be pregnant, women in nursing

Design outcomes

Primary

MeasureTime frame
1) Improvement of insulin resistance 2) Reduction of oxidative stress

Secondary

MeasureTime frame
1) Change of HCV-RNA 2) Improvement of loss of zinc 3) Improvement of BTR 4) Incidence of HCC 5) Occurrence of side effect

Countries

Japan

Contacts

Public ContactIsao Hidaka

Yamaguchi Univercity Graduate School of Medicine Department of Gastroenterology and Hepatology

isao-h@yamaguchi-u.ac.jp0836-22-2241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026